MERSANA THERAPEUTICS INC — Form D

MERSANA THERAPEUTICS INC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-03-03. The offering totals $35.5M, of which $10.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (48)

Showing 25 of 48 people.

NameRoleLocation
Thomas BeckDirectorMilwaukee, WI
Elaine JonesDirectorSOUTH SAN FRANCISCO, CA
Sara NayeemDirectorMenlo Park, CA
WAYNE FOSTERExecutive OfficerCAMBRIDGE, MA
David MottExecutive OfficerChevy Chase, MD
Peter ParkExecutive OfficerSan Francisco, CA
Michael J KaufmanExecutive OfficerNew York, NY
Sara J NayeemDirectorBOSTON, MA
C. Boyd ClarkeDirectorMadison, WI
David G MottDirectorCAMBRIDGE, MA
Sara G NayeemDirectorCAMBRIDGE, MA
David MottDirectorChevy Chase, MD
TIMOTHY LOWINGERExecutive OfficerCAMBRIDGE, MA
ELAINE J JONESDirectorCAMBRIDGE, MA
THOMAS J BECKDirectorCAMBRIDGE, MA
ANNA PROTOPAPASDirectorCAMBRIDGE, MA
ANNA PROTOPAPASExecutive OfficerCAMBRIDGE, MA
EVA JACKExecutive OfficerCAMBRIDGE, MA
DONALD BERGSTROMExecutive OfficerCAMBRIDGE, MA
WAYNE J FOSTERExecutive OfficerCAMBRIDGE, MA
Wayne B FosterExecutive OfficerCambridge, MA
Nicholas G BacopoulosDirectorCambridge, MA
Nicholas G BacopoulosExecutive OfficerCambridge, MA
Timothy B LowingerExecutive OfficerCambridge, MA
Thomas G BeckDirectorCambridge, MA

Other filings by this issuer (8)

FiledFormOfferingSold
2016-06-24D$33.1M$33.1M
2016-03-01D/A$35.5M$10.1M
2014-04-08D/A$14.5M$14.5M
2013-10-09D$14.5M$5.0M
2012-08-09D$27.0M$12.5M
2012-04-18D/A$10.0M$10.0M
2011-04-21D$10.0M$6.0M
2010-02-26D$3.5M$2.5M

More